A carregar...
Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280745/ https://ncbi.nlm.nih.gov/pubmed/32581793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00827 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|